The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With Metoprolol.
- Journal:
- Annals of Internal Medicine
- Published:
- Affiliations:
- 3
- Authors:
- 4
| Institutions | Authors | Share |
|---|---|---|
| Vanderbilt University Medical Center (VUMC), United States of America (USA) | 0.50 | |
| University of Pennsylvania (Penn), United States of America (USA) | 0.50 |